Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 35Pheochromocytoma 14Pituitary Neoplasms 12Thyroid Neoplasms 11Carcinoma, Neuroendocrine 11Thyroid Cancer, Papillary 9Adrenocortical Carcinoma 9Sarcoma 8Paraganglioma 8Adrenal Gland Neoplasms 7Small Cell Lung Carcinoma 6Neuroblastoma 6Cushing Syndrome 6Parathyroid Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Carcinoma, Medullary 5Carcinoid Tumor 5Pancreatic Neoplasms 4Osteosarcoma 4Multiple Endocrine Neoplasia Type 1 4Meningioma 4Insulinoma 4Cholangiocarcinoma 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Adenoma, Islet Cell 4Adenocarcinoma, Follicular 4Thyroid Carcinoma, Anaplastic 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lewy Body Disease × Endocrine × 30 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡